Purchase Order HHSN272201400969P
- Not listed
- This is a federal purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The $5,610 firm fixed price award has a completion date of September 12, 2014 and does not utilize any set-aside provisions. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has previously supported genomic research and diagnostic projects...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for TruSeq reagent kits. The $15,266.68 award has a completion date of September 10, 2015 and does not have a set-aside designation. Through past prime contract awards, Illumina has provided a range of sequencing systems, reagents, and services to support genomic research and diagnostics across...
- This is a $15,395.83 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for TruSeq reagent kits. The award has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and subcontracts from federal agencies like NIH, CDC, USDA, and VA to provide a range of sequencing...
- This is a $7,362.19 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the TRUSEQ SBS KIT V3. The award has no set-aside designation. Illumina is a manufacturer of sequencing and array-based genomic analysis instruments and reagents, and has provided a range of sequencing systems, reagents, and related products to support research and diagnostics across various...
- This $3,277.99 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for the provision of a TRUSEQ RNA SAMPLE KIT to support NIAID's research and development activities. No set-aside designation is mentioned. Illumina has received multiple prior federal...
- This is a $11,439.25 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for ILLUMINA TRUSEQ REAGENT KITS. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and VA to support their genomic sequencing and analysis...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of the TruSeq RNA Sample Prep Kit. The award has a ceiling value of $3,258.00 and a completion date of March 26, 2015. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis that has received past prime federal contract awards from...
- This firm fixed-price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $8,366.17 award is for the procurement of Illumina's TruSeq DNA Sample Prep Kit Set A, which supports sample preparation for genomic sequencing. Illumina has a history of prime federal contract and subcontract...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award, valued at $5,277.25, is for the provision of sequencing kits to support NIAID's research and diagnostics work. Illumina has been a long-standing provider of sequencing solutions to various federal agencies including the Centers for...
- This firm fixed-price purchase order was awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The $3,421.50 contract is for the provision of TRUSEQ KITS, with a period of performance ending on July 21, 2015. The award did not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing sequencing systems, reagents, and services to support research and diagnostics for various federal agencies including the NIH, CDC, USDA, and VA. This award appears to be part of Illumina's existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, which is intended to support nucleic acid sequencing needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 8/28/14 |